-
1 Comment
Teladoc Health, Inc is currently in a long term downtrend where the price is trading 17.6% below its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.0.
Teladoc Health, Inc's total revenue rose by 145.0% to $383M since the same quarter in the previous year.
Its net income has dropped by 1968.7% to $-394M since the same quarter in the previous year.
Finally, its free cash flow fell by 939.2% to $-124M since the same quarter in the previous year.
Based on the above factors, Teladoc Health, Inc gets an overall score of 2/5.
Exchange | NYSE |
---|---|
ISIN | US87918A1051 |
CurrencyCode | USD |
Industry | Health Information Services |
Sector | Healthcare |
Market Cap | 1B |
---|---|
PE Ratio | None |
Beta | 1.74 |
Target Price | 9.4474 |
Dividend Yield | None |
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TDOC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025